In this method, EpCAM−/+ tumor cells are enriched by depletion of CD45+ hematopoietic cells; the enriched CTCs are then cultured in vitro, allowing for a sufficient amount of secreted marker proteins to accumulate and form immunospots, as dying tumor cells do not secrete adequate protein amounts and thus are not detected [242]. Here, EPCAM is linked to neoplasm.